Neumora Therapeutics, Inc. Common Stock
NMRANASDAQHealthcare● Active
$1.62
$-0.01(-0.61%)
Market Cap$300160469
P/E Ratio—
52W High$3.65
52W Low$0.716
Neumora Therapeutics, Inc. Common Stock (NMRA) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NMRA · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.18B | $0.31B | $0.45B | $0.37B | $0.41B |
| Net Receivables | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $0.19B | $0.31B | $0.48B | $0.39B | $0.42B |
| PP&E Net | $0.00B | $0.00B | $0.01B | $0.01B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.19B | $0.32B | $0.50B | $0.43B | $0.43B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| Total Current Liabilities | $0.03B | $0.03B | $0.03B | $0.02B | $0.02B |
| Long-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.09B | $0.03B | $0.03B | $0.87B | $0.75B |
| Stockholders Equity | |||||
| Retained Earnings | ($1.18B) | ($0.95B) | ($0.70B) | ($0.47B) | ($0.34B) |
| Total Stockholders Equity | $0.10B | $0.29B | $0.47B | ($0.45B) | ($0.33B) |
| Total Liab & Equity(computed) | $0.19B | $0.32B | $0.50B | $0.43B | $0.43B |
| Debt Summary | |||||
| Total Debt | $0.00B | $0.00B | $0.01B | $0.01B | $0.00B |
| Net Debt | ($0.18B) | ($0.14B) | ($0.37B) | ($0.23B) | ($0.41B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Neumora Therapeutics, Inc. Common Stock data
About Neumora Therapeutics, Inc. Common Stock (NMRA) Balance Sheet
Neumora Therapeutics, Inc. Common Stock (NMRA) balance sheet shows total assets of $0.19B with cash of $0.18B. Total liabilities are $0.09B, total debt $0.00B, and stockholders equity $0.10B.
Frequently asked questions
NMRA · 4 questionsNeumora Therapeutics, Inc. Common Stock has total debt of $0.00B with net debt of ($0.18B).
NMRA total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10